In its May 4 issue, Le Devoir published two articles on the importance of the relationship between research and treatment at the Douglas

Impaired melatonin secretion may play a role in premenstrual syndrome

McGill's Faculty of Medicine wants to make mental health a key priority

The Conseil québécois d’agrément (CQA) awarded the Douglas Institute with Milieu Novateur certification.

Nomination > Dr. Suzane Renaud was inaugurated as President of the Canadian Psychiatric Association.

Johanne Renaud, MD, was awarded the 2012 Klerman Prize Honorable Mention, which honors exceptional clinical research by a NARSAD Young Investigator Grantee. Dr. Renaud’s studies have demonstrated that, although most children and adolescent suic

Wellington Centre > Its mission is to have users actively participate in their own journey towards recovery, with the help of peer experts.

Brain Imaging Centre > Inaugurated May 14, this is the first brain imaging centre in Quebec dedicated to psychiatry and mental health.

New Executive Director >The Douglas Institute is pleased to welcome Ms. Lynne McVey as the Institute's new Executive Director.

The Short-Term Assessment of Risk and Treatability (START) clinical guide has been revamped. The new version clarifies a number of assessment criteria, such as the client’s mental state, emotional state and treatability. The update also inclu